Cargando…

Ventricular fibrillation in Graves disease reveals a rare SCN5A mutation with W1191X variant associated with Brugada syndrome

Detalles Bibliográficos
Autores principales:	Stawiarski, Kristin, Clarke, John-Ross D., Pollack, Ari, Winslow, Robert, Majumdar, Sachin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897746/ https://www.ncbi.nlm.nih.gov/pubmed/33665110 http://dx.doi.org/10.1016/j.hrcr.2020.11.010

Ejemplares similares

SAT-595 Ventricular Fibrillation as a Manifestation of Hyperthyroidism
por: Stawiarski, Kristin, et al.
Publicado: (2019)

Novel SCN5A p.W697X Nonsense Mutation Segregation in a Family with Brugada Syndrome
por: Micaglio, Emanuele, et al.
Publicado: (2019)

SCN5A gene mutations and the risk of ventricular fibrillation and syncope in Brugada syndrome patients: A meta‐analysis
por: Raharjo, Sunu Budhi, et al.
Publicado: (2018)

Vaping tetrahydrocannabinol unmasks Brugada pattern and induces ventricular fibrillation in Brugada syndrome: a case report
por: Seri, Amith, et al.
Publicado: (2022)

Age and genetics are associated with ventricular fibrillation but not with monomorphic ventricular tachycardia in Brugada syndrome
por: Pannone, L, et al.
Publicado: (2023)

SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients
por: Ricci, Maria Teresa, et al.
Publicado: (2014)

In vivo Dominant-Negative Effect of an SCN5A Brugada Syndrome Variant
por: Doisne, Nicolas, et al.
Publicado: (2021)

Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome
por: Dakkak, Melissa, et al.
Publicado: (2015)

Regional patterns of activation during induced ventricular fibrillation in Brugada Syndrome
por: Sanchez Munoz, J J
Publicado: (2023)

Meta-Analysis of Risk Stratification of SCN5A With Brugada Syndrome: Is SCN5A Always a Marker of Low Risk?
por: Yang, Yihan, et al.
Publicado: (2019)

Pulmonary Vein Thrombosis in a Patient With Multiple Myeloma on Treatment With Lenalidomide
por: Stawiarski, Kristin M., et al.
Publicado: (2021)

SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome
por: Makarawate, Pattarapong, et al.
Publicado: (2017)

IRX3 variant as a modifier of Brugada syndrome with frequent ventricular fibrillation
por: Kimura, Yoshitaka, et al.
Publicado: (2016)

COVID-19 Vaccination-Induced Ventricular Fibrillation in an Afebrile Patient With Brugada Syndrome
por: Lim, Kyung Hee, et al.
Publicado: (2022)

Ventricular fibrillation in lone atrial fibrillation as clinical manifestation of latent Brugada syndrome: Usefulness of flecainide testing
por: Pappone, Carlo, et al.
Publicado: (2015)

SCN5A Mutation Type and a Genetic Risk Score Associate Variably With Brugada Syndrome Phenotype in SCN5A Families
por: Wijeyeratne, Yanushi D., et al.
Publicado: (2020)

MJRA1.19.1 - Integrated EMI Major Release Candidates
por: Members of EMI collaboration
Publicado: (Febr)

1191. Hand Hygiene Education: Why Is It so Critical to Tissue Banking?
por: Imrit-Thomas, Kavita D, et al.
Publicado: (2019)

Su1191 ADULT-ONSET AUTOIMMUNE ENTEROPATHY: A SCOPING REVIEW
por: Liu, Jasmine, et al.
Publicado: (2020)

SCN5A Mutations in Brugada Syndrome Are Associated with Increased Cardiac Dimensions and Reduced Contractility
por: van Hoorn, Frans, et al.
Publicado: (2012)

A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG
por: Turker, Isik, et al.
Publicado: (2016)

Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype
por: Micaglio, Emanuele, et al.
Publicado: (2019)

Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value
por: Pappone, Carlo, et al.
Publicado: (2021)

Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome
por: Chen, Gan-Xiao, et al.
Publicado: (2022)

Brugada Syndrome Associated with Different Heterozygous SCN5A Variants in Two Unrelated Families
por: Molitor, Nadine, et al.
Publicado: (2022)

Recurrent cardiac events in patients with idiopathic ventricular fibrillation, excluding patients with the Brugada syndrome
por: Champagne, Jean, et al.
Publicado: (2005)

Ventricular fibrillation/Brugada-like ST segment elevation: First presentation of subarachnoid hemorrhage
por: Ösken, Altuğ, et al.
Publicado: (2016)

Categorization of radioactive sources. Revision of IAEA-TECDOC-1191, Categorization of radiation sources
Publicado: (2003)

DPD Scintigraphy for diagnosis of amyloidosis in 1191 patients– a single centre experience
por: Hutt, David, et al.
Publicado: (2015)

Utilizing Multiple in Silico Analyses to Identify Putative Causal SCN5A Variants in Brugada Syndrome
por: Juang, Jyh-Ming Jimmy, et al.
Publicado: (2014)

Inaccurate diagnosis of Brugada syndrome in a healthy woman based on SCN5A mutation classification
por: Warring, Simrit K., et al.
Publicado: (2017)

Sex‐Dependent Phenotypic Variability of an SCN5A Mutation: Brugada Syndrome and Sick Sinus Syndrome
por: Aizawa, Yoshiyasu, et al.
Publicado: (2018)

Functional Epicardial Conduction Disturbances Due to a SCN5A Variant Associated With Brugada Syndrome
por: Renard, Estelle, et al.
Publicado: (2023)

Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights
por: Frosio, Anthony, et al.
Publicado: (2023)

“Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient With a Common SCN5A R1193Q Polymorphism
por: Li, Linling, et al.
Publicado: (2019)

A successfully treated Brugada syndrome presenting in ventricular fibrillation preceded by fever and concomitant hypercalcemia
por: Nakamura, Hiroki, et al.
Publicado: (2022)

Ventricular Fibrillation in an Afebrile COVID-19 Patient Presenting With Transient Type-I Brugada Pattern
por: Kreinbrook, Judah A, et al.
Publicado: (2023)

H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters
por: Matsumura, Hiroya, et al.
Publicado: (2017)

Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome
por: Nakajima, Tadashi, et al.
Publicado: (2021)

In vivo studies of Scn5a+/− mice modeling Brugada syndrome demonstrate both conduction and repolarization abnormalities
por: Martin, Claire A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_lfau6lt8h7n79703ngfbgubdr2